Blood Pressure and Decline in Kidney Function in Patients With Atherosclerotic Vascular Disease: A Cohort Study

American Journal of Kidney Diseases

Volumn 54, Issue 5, 2009, Pages 820-829

  Vlek, Anne L M ^a   van der Graaf, Yolanda ^a   Braam, Branko ^b   Moll, Frans L ^a   Nathoe, Hendrik M ^a   Visseren, Frank L J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

albuminuria; blood pressure; epidemiology; Hypertension; renal function; vascular disease

Indexed keywords

ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ALBUMINURIA; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLOOD PRESSURE MEASUREMENT; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PROSPECTIVE STUDY; SCREENING; SYSTOLIC BLOOD PRESSURE;

ATHEROSCLEROSIS; BLOOD PRESSURE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 70350202522     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.07.007     Document Type: Article

References (44)

1. Gilbertson D.T., Liu J., Xue J.L., et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 16 12 (2005) 3736-3741
2. Stengel B., Billon S., Van Dijk P.C., et al. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant 18 9 (2003) 1824-1833
3. Lindeman R.D., Tobin J., and Shock N.W. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33 4 (1985) 278-285
4. Wesson Jr. L.G. Renal hemodynamics in physiological states. Physiology of the Human Kidney (1969), Grune & Stratton, New York 96-108
5. Hsu C.Y., McCulloch C.E., Darbinian J., Go A.S., and Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 165 8 (2005) 923-928
6. Haroun M.K., Jaar B.G., Hoffman S.C., Comstock G.W., Klag M.J., and Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14 11 (2003) 2934-2941
7. Klag M.J., Whelton P.K., Randall B.L., et al. Blood pressure and end-stage renal disease in men. N Engl J Med 334 1 (1996) 13-18
8. Ishida K., Ishida H., Narita M., et al. Factors affecting renal function in 119 985 adults over three years. QJM 94 10 (2001) 541-550
9. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., and Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 1 (2006) 21-28
10. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., and Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291 7 (2004) 844-850
11. Peterson J.C., Adler S., Burkart J.M., et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123 10 (1995) 754-762
12. Iseki K., Iseki C., Ikemiya Y., and Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 49 3 (1996) 800-805
13. Manttari M., Tiula E., Alikoski T., and Manninen V. Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 26 4 (1995) 670-675
14. Klahr S., Levey A.S., Beck G.J., et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330 13 (1994) 877-884
15. Knight E.L., Stampfer M.J., Hankinson S.E., Spiegelman D., and Curhan G.C. The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med 138 6 (2003) 460-467
16. Freedman B.I., Iskandar S.S., and Appel R.G. The link between hypertension and nephrosclerosis. Am J Kidney Dis 25 2 (1995) 207-221
17. Elsayed E.F., Tighiouart H., Griffith J., et al. Cardiovascular disease and subsequent kidney disease. Arch Intern Med 167 11 (2007) 1130-1136
18. Kasiske B.L. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 31 5 (1987) 1153-1159
19. Simons P.C., Algra A., van de Laak M.F., Grobbee D.E., and van der G.Y. Second Manifestations of ARTerial disease (SMART) Study: rationale and design. Eur J Epidemiol 15 9 (1999) 773-781
20. Brosius III F.C., Hostetter T.H., Kelepouris E., et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in Collaboration With the National Kidney Foundation. Hypertension 48 4 (2006) 751-755
21. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 6 (2003) 1206-1252
22. Coresh J., Byrd-Holt D., Astor B.C., et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16 1 (2005) 180-188
23. Garg A.X., Kiberd B.A., Clark W.F., Haynes R.B., and Clase C.M. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int 61 6 (2002) 2165-2175
24. Davies D.F., and Shock N.W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 29 5 (1950) 496-507
25. Rowe J.W., Andres R., Tobin J.D., Norris A.H., and Shock N.W. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 31 2 (1976) 155-163
26. Kronborg J., Solbu M., Njolstad I., Toft I., Eriksen B.O., and Jenssen T. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant 23 9 (2008) 2818-2826
27. Imai E., Horio M., Yamagata K., et al. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res 31 3 (2008) 433-441
28. Halbesma N., Brantsma A.H., Bakker S.J., et al. Gender differences in predictors of the decline of renal function in the general population. Kidney Int 74 4 (2008) 505-512
29. Eriksen B.O., and Ingebretsen O.C. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 69 2 (2006) 375-382
30. Nakamura S., Yoshihara F., Kamide K., et al. Renal function in patients with abdominal aortic aneurysm. Comparison with hypertensive patients. Kidney Blood Press Res 29 2 (2006) 67-73
31. Neugarten J., Acharya A., and Silbiger S.R. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 11 2 (2000) 319-329
32. Baylis C. Sexual dimorphism of the aging kidney: role of nitric oxide deficiency. Physiology (Bethesda) 23 (2008) 142-150
33. Jafar T.H., Stark P.C., Schmid C.H., et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 139 4 (2003) 244-252
34. Schaeffner E.S., Kurth T., Bowman T.S., Gelber R.P., and Gaziano J.M. Blood pressure measures and risk of chronic kidney disease in men. Nephrol Dial Transplant 23 4 (2008) 1246-1251
35. Tozawa M., Iseki K., Iseki C., Kinjo K., Ikemiya Y., and Takishita S. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension 41 6 (2003) 1341-1345
36. Froissart M., Rossert J., Jacquot C., Paillard M., and Houillier P. Predictive performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 16 3 (2005) 763-773
37. Lindeman R.D., Tobin J.D., and Shock N.W. Association between blood pressure and the rate of decline in renal function with age. Kidney Int 26 6 (1984) 861-868
38. Bidani A.K., and Griffin K.A. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension 44 5 (2004) 595-601
39. Young J.H., Klag M.J., Muntner P., Whyte J.L., Pahor M., and Coresh J. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol 13 11 (2002) 2776-2782
40. Williams B., Lindholm L.H., and Sever P. Systolic pressure is all that matters. Lancet 371 9631 (2008) 2219-2221
41. Obermayr R.P., Temml C., Knechtelsdorfer M., et al. Predictors of new-onset decline in kidney function in a general middle-European population. Nephrol Dial Transplant 23 4 (2008) 1265-1273
42. Coresh J., Wei G.L., McQuillan G., et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 161 9 (2001) 1207-1216
43. Yokoyama H., Tomonaga O., Hirayama M., et al. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia 40 4 (1997) 405-411
44. Kes P., and Ratkovic-Gusic I. The role of arterial hypertension in progression of renal failure. Kidney Int Suppl 55 (1996) S72-S74